Utilization of Cardiovascular Procedures, Consultation Services, and Cardioprotective Medications Among Type 2 Myocardial Infarction Patients
In the United States, T2MI patients received less cardiovascular testing and secondary preventative therapies than T1MI patients.
Authors
- Caroline Schaefer (ORCID: https://orcid.org/0000-0003-1898-0644)
- Saumil Datar (ORCID: https://orcid.org/0000-0002-0772-2108)
- Meera Kapadia (ORCID: https://orcid.org/0000-0001-7331-7437)
- James Louis Januzzi (ORCID: https://orcid.org/0000-0002-8338-1798)
- Harsh Goel (ORCID: https://orcid.org/0000-0003-0081-9852)
- Lee Revere (ORCID: https://orcid.org/0000-0003-3230-0115)
- Karan V. Goenka
- Cian P. McCarthy (ORCID: https://orcid.org/0000-0003-4944-0034)
- Adwait G Mehta
Institutions
- Harvard University (US)
- University of Florida Health (US)
- Massachusetts General Hospital (US)
- The University of Texas Health Science Center (US)
- The University of Texas Health Science Center at Houston (US)
Publication Details
- Journal
- JACC Advances
- Published
- 2025-02-20
- DOI
- https://doi.org/10.1016/j.jacadv.2025.101629
- Primary Topic
- Cardiac Health and Mental Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of Texas Health Science Center at Houston